Endovascular Embolization
Applied
Type
ReinforcementConfidence
78%
Created
Mar 27, 2026
Evidence
1 source
Rationale
The 2025 systematic review by Wagner et al. is directly relevant to this section on endovascular embolization in trauma, providing updated guideline-level evidence supporting angioembolization for hemorrhage control in severely injured patients. Given the article's moderate relevance score (65/100) and that the existing content already covers the core indications and WSES recommendations, a citation-only integration is appropriate. The new citation is added as a reinforcing sentence at the end of the WSES Recommendation paragraph to acknowledge the updated evidence without disrupting the existing structure or duplicating content.
Evidence
Content Changes
removedadded
<!-- type: treatment --> **Table 16.3. Endovascular Embolization Agents and Applications** | **Agent Type** | **Examples** | **Best For** | | --- | --- | --- | | **Coils** | Pushable, detachable | Large vessel occlusion, pseudoaneurysms | | **Vascular Plugs** | Amplatzer | Rapid large vessel occlusion | | **Gelfoam** | Absorbable gelatin | Temporary hemostasis, small vessels | | **Liquid Embolics** | NBCA, Onyx | Distal vessels, AV fistulae | **Indications**: - Pelvic hemorrhage (pelvic ring fractures) [@coccolini2017-wses] - Solid-organ trauma (spleen, liver, kidney) - Junctional or retroperitoneal bleeding **WSES Recommendation**: Angioembolization as first-line for uncontrolled pelvic bleeding where available, with preperitoneal pelvic packing as complementary when angiography is delayed [@coccolini2017-wses]. A 2025 systematic review and clinical practice guideline update further supports endovascular management of hemorrhage and vascular lesions in patients with multiple and/or severe injuries [@wagner2025-j].